INSTRUMENTS FOR MEAS & TESTING OF ELECTRICITY & ELEC SIGNALS
Transcat Inc
TRNS
Transcat Inc is a provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The Company is focused on providing services and products to high regulated industries, particularly the life sciences industry, which includes pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses, as well as aerospace and defense, and energy and utilities. It conducts business through two operating segments: Services and Distribution.
Last trade$100.74
Day change-$0.96 (-0.94%)
Day range$99.81 – $102.59
Volume62,600
Market cap$956M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$956.47M
Price / earnings
208.38×
Price / book
3.09×
Price / sales
2.63×
EV / sales
2.94×
EV / EBITDA
26×
Profitability
Earnings per share
$0.49
Return on assets
0.91%
Return on equity
1.48%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.38×
Current ratio
2.57×
Quick ratio
2.19×
Cash ratio
0.15×
Cash flow
Price / cash flow
25.64×
Price / free cash flow
41.63×
Free cash flow
$22.97M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for TRNS, quarterly periods
Line item
Q2 FY2027 Sep 26, 2026
Q1 FY2027 Jun 27, 2026
Q4 FY2026 Mar 28, 2026
Q3 FY2026 Dec 27, 2025
Q2 FY2026 Sep 27, 2025
Q1 FY2026 Jun 28, 2025
Q4 FY2025 Mar 29, 2025
Q3 FY2025 Dec 28, 2024
Revenue
$97.09M
$92.95M
$89.33M
$83.86M
$82.27M
$76.42M
$77.13M
$66.75M
Cost of revenue
$64.46M
$62.21M
$58.86M
$58.6M
$55.51M
$50.6M
$51.22M
$47.08M
Gross profit
$32.63M
$30.73M
$30.47M
$25.25M
$26.76M
$25.82M
$25.91M
$19.68M
Selling, general and administrative
$27.6M
$27.02M
$26.14M
$25.17M
$23.26M
$20.48M
$18.97M
$17.58M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$27.6M
$27.02M
$26.14M
$25.17M
$23.26M
$20.48M
$18.97M
$17.58M
Operating income
$5.03M
$3.72M
$4.33M
$88K
$3.51M
$5.34M
$6.94M
$2.1M
Interest expense
-$1.59M
-$1.52M
-$1.38M
-$1.5M
-$1.27M
-$451K
-$471K
-$199K
Income before taxes
$3.18M
$2.19M
$2.83M
-$1.44M
$2.03M
$4.57M
$6.26M
$3.13M
Income taxes
$767K
$854K
$887K
-$338K
$760K
$1.3M
$1.79M
$772K
Net income
$2.41M
$1.33M
$1.95M
-$1.1M
$1.27M
$3.26M
$4.46M
$2.36M
Net income attributable to common shareholders
$2.41M
$1.33M
$1.95M
-$1.1M
$1.27M
$3.26M
$4.46M
$2.36M
EBITDA
$11.88M
$10.68M
$11.28M
$7.22M
$9.99M
$10.94M
$12.57M
$6.53M
Basic earnings per share
$0.26
$0.14
$0.21
-$0.12
$0.14
$0.35
$0.48
$0.26
Diluted earnings per share
$0.25
$0.14
$0.21
-$0.12
$0.14
$0.35
$0.48
$0.25
Recent news
Company coverage with links to the original publishers.
Transcat, Inc. (TRNS) is highlighted as a suitable candidate for short-term trend investors based on Zacks' 'Recent Price Strength' screen. The stock has gained 8.3% over 12 weeks and 17.7% over the past four weeks, currently trading at 85.1% of its 52-week high-low range. TRNS carries a Zacks Rank #1 (Strong Buy) rating and an Average Broker Recommendation of #1, indicating strong fundamental strength and positive near-term price performance outlook.
Transcat, Inc. (TRNS) has been upgraded to a Zacks Rank #1 (Strong Buy) rating, reflecting an upward trend in earnings estimates over the past three months with a consensus estimate increase of 18.6%. The upgrade positions the company in the top 5% of Zacks-covered stocks, suggesting potential for near-term stock price appreciation driven by improving business fundamentals and institutional investor buying pressure.
Transcat, Inc. (TRNS) is highlighted as a strong momentum pick with a Zacks Rank #1 (Strong Buy) rating and a Momentum Style Score of B. The stock has outperformed its industry and the broader market, rising 73.01% over the past year compared to the S&P 500's 9.35%. Recent earnings estimate revisions have been positive, with consensus estimates increasing from $1.74 to $2.06 in the past 60 days.
Transcat, Inc. (TRNS), a calibration and laboratory services company, has been identified as a stock with strong buy potential. The company holds a Zacks Rank #1 rating with consensus earnings estimates increasing 5.8% over the last 60 days. TRNS shares gained 7.8% over three months and possess an A Momentum Score, outperforming the S&P 500's decline of 0.1%.
Zacks has added five stocks to its Strong Buy list based on increasing consensus earnings estimates over the last 60 days. The stocks include Diamondback Energy (oil and gas), Transcat (calibration services), Woori Financial Group (financial services), Peloton Interactive (fitness), and Turtle Beach Corporation (audio/gaming technology).
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
No prior dividend records found.
Stock splits
Historical share-structure events and their execution dates.